A Phase I/IIa study to investigate the safety and efficacy of APC201 for the treatment of pain associated with osteoarthritis of the knee
Year: 2023
Type: Pharmaceutical - Pain
Phase: II
Indication: Knee Osteoarthritis
A Phase 4, Randomized, Double blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults with a History of inadequate Response to Oral Preventive Medications
Year: 2023
Type: Device
Phase: IV
Indication: Migraine
A Pilot Study Assessing Preliminary Safety and Efficacy of The ShiraTronics Migraine Therapy System in RELIEVing, Interrupting, and Preventing Chronic Migraine (RELIEV-CM).
Year: 2023
Type: Device
Phase: Pilot
Indication: Migraine
XanaCIDD: A Double-Blind, Randomized, Placebo Controlled, Parallel-Group Trial to Assess the Safety, Tolerability, and Efficacy of Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition.
Year: 2023
Type: Pharmaceutical - Other
Phase: II
A Phase 2, Randomized, Observer-Blinded Study to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle and Quadrivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine With Matrix-M™ Adjuvant in Healthy Participants ≥ 50 to ≤ 80 Years of Age.
Year: 2023
Type: Vaccine
Phase: II
Indication: Healthy
A First-in-Human Open-Label Phase 1/2a Study to Evaluate Safety, Tolerability and Efficacy of a Single Intra-Articular Injection of Allogeneic Mesenchymal Stem Cells Selected for Integrin α10β1 (XSTEM-OA) in Adult Patients with Symptomatic Knee Osteoarthritis.
Year: 2023
Type: Musculoskeletal
Phase: First-in-Human, I, IIa
Indication: Knee Osteoarthritis
A Prospective, Open-Label, Multi-Center Trial to Evaluate the Safety and Effectiveness of Ultra Low Frequency Spinal Cord Stimulation in Patients With Chronic Low Back Pain.
Year: 2023
Type: Device
Phase: N/A
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain
